Supernus Pharmaceuticals | SUPN - Trade Creditors


Supernus Pharmaceuticals reported $5.59M in Trade Creditors for its fiscal quarter ending in June of 2026.





Trade Creditors Change Date
Abbott USD 4.68B 439M Mar/2026
ANI Pharmaceuticals USD 69.69M 7.11M Mar/2026
Aurora Cannabis CAD 9.31M 58.72M Mar/2026
Bristol-Myers Squibb USD 4.16B 76M Jun/2026
Canopy Growth CAD 34.82M 14.85M Mar/2026
Cara Therapeutics USD 4.62M 1.4M Mar/2026
Corcept Therapeutics USD 14.91M 18.4M Jun/2026
Eisai JPY 87.53B 11.64B Jun/2026
Eli Lilly USD 6.11B 1.08B Jun/2026
Novo Nordisk DKK 14.59B 212M Jun/2026
Pacira USD 17.51M 3.5M Jun/2026
Perrigo USD 400.4M 34.4M Jun/2026
Pfizer USD 4.58B 75M Jun/2026
Supernus Pharmaceuticals USD 5.59M 4.58M Jun/2026
United Therapeutics USD 497.8M 500K Jun/2026
Xeris Pharmaceuticals USD 11.47M 8.39M Mar/2026